Clinical Trial Update: Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia [Phase 3]

View source ↗

Summary

A Phase 3 trial updated on dosing of vincristine (low-dose vs high-dose) plus combination chemotherapy for relapsed B-cell acute lymphoblastic leukemia in pedia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia
• Childhood Acute Lymphoblastic Leukemia

Drugs mentioned

• Vincristine (vincristine)

Snippet

Sponsor: Children's Oncology Group | Conditions: B-cell Childhood Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia | Phase 3 | Status: COMPLETED | Results posted: 2017-05-12